Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,421 GBX | +0.75% | -0.44% | +17.14% |
06-27 | US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug | RE |
06-26 | European Equities Close Lower in Wednesday Trading | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.14% | 242B | |
+55.95% | 819B | |
+43.33% | 638B | |
-6.98% | 351B | |
+19.08% | 329B | |
+9.05% | 298B | |
+2.78% | 225B | |
+13.30% | 217B | |
+8.91% | 168B | |
-3.44% | 158B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca's Rare Inflammatory Disease Drug for Adults Wins First-in-Class Nod in China